SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions Inc., a leading provider of advanced technologies and outsourced services to the global pharmaceutical, biotechnology and consumer health industry announced its financial results for the fourth quarter and fiscal year ended June 30, 2007. Catalent recognized net revenue for the year of $1.7 billion, and EBITDA from continuing operations of $35.0 million after giving effect to the Acquisition (described in detail below) and related purchase method of accounting adjustments. Adjusted EBITDA as detailed in the attached schedules was $332.5 million. EBITDA and adjusted EBITDA are defined below under “Non-GAAP Financial Matters”.
